ilygod: Ha, that would be nice. I'm w/u all the way. For the last 4 quarters, BDSI has surprised on the upside. Averaged out, it would come to 63.9%. I think it will beat the street again on the $3.54m top estimate. I hope for $4.6m and we could see nice bottom line. Few retail investors know about BDSI but i think w/each amazing quarer on eps, BDSI will gain more attention. Maybe some big pharma is already sniffing around. Maybe it already got a lowball offer w/the exponential sequential quar to quar eps performance and bup closer to FDA approval and low pps. I do feel lots of folks underestimated the stock. W/big pharma running out of patents, they are looking for developers, and BDSI is a profitable commercial outfit w/great profit margins and low expenses.